Document Detail


Advances in understanding the aetiology of atypical Haemolytic Uraemic Syndrome.
MedLine Citation:
PMID:  20629662     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Atypical Haemolytic Uraemic Syndrome (aHUS) is a thrombotic microangiopathy that often provokes irreversible renal damage and post-transplantation recurrence. Studies performed during the last decade have shown that 50-60% of aHUS patients present genetic or acquired defects in the complement system that enhance the initial endothelial damage and favour disease development. This review analyses the complement proteins and processes that are disturbed in aHUS patients, and outlines the relevance of a prompt genetic/molecular diagnosis for improving clinical management and prognosis.
Authors:
Pilar Sánchez-Corral; Marta Melgosa
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2010-07-14
Journal Detail:
Title:  British journal of haematology     Volume:  150     ISSN:  1365-2141     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-08-19     Completed Date:  2010-10-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  529-42     Citation Subset:  IM    
Affiliation:
Research, University Hospital La Paz, Madrid, Spain. psanchez.hulp@salud.madrid.org
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Complement Pathway, Alternative / genetics,  immunology
Genetic Predisposition to Disease
Hemolytic-Uremic Syndrome / etiology*,  genetics,  immunology,  therapy
Humans
Kidney Transplantation
Mutation

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell ...
Next Document:  Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor liga...